{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,28]],"date-time":"2024-01-28T08:08:02Z","timestamp":1706429282188},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1982,10,1]],"date-time":"1982-10-01T00:00:00Z","timestamp":402278400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Agents and Actions"],"published-print":{"date-parts":[[1982,10]]},"DOI":"10.1007\/bf01965075","type":"journal-article","created":{"date-parts":[[2005,7,30]],"date-time":"2005-07-30T03:21:35Z","timestamp":1122693695000},"page":"657-661","source":"Crossref","is-referenced-by-count":1,"title":["Thrombocytopenia provoked by carrageenan in rabbits and the inhibitory effect of lysozyme"],"prefix":"10.1007","volume":"12","author":[{"given":"Camillo","family":"Bianchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01965075_CR1","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0014-2999(81)90024-8","volume":"71","author":"C. Bianchi","year":"1981","unstructured":"C. Bianchi,Is Fleming's lysozyme an analgesic agent? An experimental reappraisal of clinical data, Eur. J. Pharmac.71, 211\u2013221 (1981).","journal-title":"Eur. J. Pharmac."},{"key":"BF01965075_CR2","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1007\/BF01978801","volume":"11","author":"C. Bianchi","year":"1981","unstructured":"C. Bianchi,Antibody-induced foot oedema, hyperalgesia and monoarticular arthritis in rats, guinea-pigs and rabbits for testing anti-inflammatory, antiarthritic agents, Agents and Actions,11, 750\u2013761 (1981).","journal-title":"Agents and Actions"},{"key":"BF01965075_CR3","first-page":"71","volume":"26","author":"A. Fleming","year":"1932\u20131933","unstructured":"A. Fleming,Lysozyme. President's address, Proc. R. Soc. Med.26, part 1, 71\u201384 (1932\u20131933).","journal-title":"Proc. R. Soc. Med."},{"key":"BF01965075_CR4","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/243331a0","volume":"243","author":"E.F. Osserman","year":"1973","unstructured":"E.F. Osserman, K. Klockars, M.J. Halper andR.E. Fischel,Effects of lysozyme on normal and transformed mammalian cells, Nature, Lond.243, 331\u2013335 (1973).","journal-title":"Nature, Lond."},{"key":"BF01965075_CR5","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1056\/NEJM197502202920813","volume":"292","author":"E.F. Osserman","year":"1975","unstructured":"E.F. Osserman,Lysozyme, New Engl. J. Med.292, 424\u2013425 (1975).","journal-title":"New Engl. J. Med."},{"key":"BF01965075_CR6","first-page":"447","volume-title":"Lysozyme in Applied Biology and Therapeutics","author":"N.R. Luzio Di","year":"1979","unstructured":"N.R. Di Luzio, Lysozyme activity: an index of macrophage functionat status. InLysozyme in Applied Biology and Therapeutics, pp. 447\u2013462 (EdsJ.T. Dingle, P.J. Jacques andI.H. Shaw). North-Holland Publishing Company, Amsterdam 1979."},{"key":"BF01965075_CR7","first-page":"817","volume":"40","author":"M.A. Spanjers","year":"1981","unstructured":"M.A. Spanjers andN.R. Di Luzio,Specificity of lysozyme mediated tumor cell cytotoxicity, Fedn Proc.40, 817 (1981).","journal-title":"Fedn Proc."},{"key":"BF01965075_CR8","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/bjc.1976.6","volume":"33","author":"G.A. Currie","year":"1976","unstructured":"G.A. Currie andS.A. Eccles,Serum lysozyme as a marker of host resistance. I. Production by macrophages resident in rat sarcomata, Br. J. Cancer33, 51\u201359 (1976).","journal-title":"Br. J. Cancer"},{"key":"BF01965075_CR9","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/bjc.1976.96","volume":"33","author":"G.A. Currie","year":"1976","unstructured":"G.A. Currie,Serum lysozyme as a marker of host resistance. 2. Patients with malignant melanoma, hypernephroma or breast carcinoma, Br. J. Cancer33, 593\u2013599 (1976).","journal-title":"Br. J. Cancer"},{"key":"BF01965075_CR10","first-page":"158","volume":"19","author":"A. Gonet","year":"1962","unstructured":"A. Gonet, J. Scherer andJ.P. Girard,Propri\u00e9t\u00e9s antalgiques du lysozyme chez les malades atteints de n\u00e9oplasies avec m\u00e9tastases osseuses, Ther. Umsch.19, 158\u2013159 (1962).","journal-title":"Ther. Umsch."},{"key":"BF01965075_CR11","first-page":"503","volume":"19","author":"J.P. Girard","year":"1962","unstructured":"J.P. Girard, J. Scherer andG. Fischer,Propri\u00e9t\u00e9s th\u00e9rapeutiques du lysozyme dans les douleurs de n\u00e9oplasie g\u00e9n\u00e9ralis\u00e9es et certaines affections virales, Ther. Umsch.19, 503\u2013506 (1962).","journal-title":"Ther. Umsch."},{"key":"BF01965075_CR12","first-page":"1882","volume":"54","author":"S. Pietro Di","year":"1963","unstructured":"S. Di Pietro andG. Pellegris.Propriet\u00e0 antalgiche del lisozima in soggetti portatori di neoplasie maligne, Minerva med.,54, 1882\u20131902 (1963).","journal-title":"Minerva med."},{"key":"BF01965075_CR13","first-page":"983","volume":"22","author":"E.G. Scolari","year":"1964","unstructured":"E.G. Scolari,Cinq an\u0161 d'exp\u00e9rience de l'action antalgique du lysozyme dans les affections malignes, M\u00e9d. Hygi\u00e8ne,22, 983 (1964).","journal-title":"M\u00e9d. Hygi\u00e8ne"},{"key":"BF01965075_CR14","first-page":"1463","volume":"94","author":"T. Toussi","year":"1964","unstructured":"T. Toussi,Nouvelle th\u00e9rapeutique de la douleur chez les canc\u00e9reux, au moyen du lysozyme (Antalzyme), Schweiz. med. Wschr.94, 1463\u20131465 (1964).","journal-title":"Schweiz. med. Wschr."},{"key":"BF01965075_CR15","unstructured":"E.G. Scolari, Method of relieving pain in cancer by injecting lysozyme free of proteinaceous impurities, US patent 3,282, 782 (1966)."},{"key":"BF01965075_CR16","first-page":"1672","volume":"2","author":"Ph. Babin","year":"1973","unstructured":"Ph. Babin andP. Babin,Lysozyme, interferon and cancer, Nouv. Presse Med.2, 1672 (1973).","journal-title":"Nouv. Presse Med."},{"key":"BF01965075_CR17","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1001\/jama.1959.03010150086022","volume":"70","author":"E.O. Bierman","year":"1959","unstructured":"E.O. Bierman,Spontaneous regression of malignant disease, J. Am. med. Ass.70, 1842 (1959).","journal-title":"J. Am. med. Ass."},{"key":"BF01965075_CR18","unstructured":"O.E. Lobstein andS.I. Dulkin,A Study of Lysozyme in Malignancy, Abstracts ACS Annual Meeting N.Y.C., N.Y. p. 6C (1954)."},{"key":"BF01965075_CR19","first-page":"1683","volume-title":"Harrison's Principles of Internal Medicine","author":"E. Fei","year":"1974","unstructured":"E. Fei andG.P. Bodey, Principles of neoplasia. InHarrison's Principles of Internal Medicine, 7th ed., pp. 1683\u20131689 (EdsM.M. Wintrobe, G.W. Thorn, R.D. Adams, E. Braunwald, K.J. Isselbacher andR.G. Petersdorf). McGraw-Hill Book Company, New York 1974.","edition":"7th ed."},{"key":"BF01965075_CR20","first-page":"107","volume-title":"Chemotherapy of Cancer Dissemination and Metastasis","author":"T. Johnson","year":"1973","unstructured":"T. Johnson, T. Gasic andG. Gasic, Platelet aggregation by fibroblasts and its enhancing effect on metastasis in mice. InChemotherapy of Cancer Dissemination and Metastasis, pp. 107\u2013117 (EdsS. Garattini andG. Franchi). Raven Press, New York 1973."},{"key":"BF01965075_CR21","first-page":"447","volume-title":"Platelets, a Multidisciplinary Approach","author":"G.I. Gasic","year":"1978","unstructured":"G.I. Gasic, B. Boettiger, J.L. Catalfamo, T.B. Gasic andG.J. Stewart, Platelet interactions in malignancy and cell transformation. Functional and biochemical studies. InPlatelets, a Multidisciplinary Approach, pp. 447\u2013456 (EdsG. De Gaetano andS. Garattini). Raven Press, New York 1978."},{"key":"BF01965075_CR22","first-page":"457","volume-title":"Platelets, a Multidisciplinary Approach","author":"P. Hilgard","year":"1978","unstructured":"P. Hilgard, Blood platelets and experimental metastases. InPlatelets, a Multidisciplinary Approach, pp. 457\u2013466 (EdsG. De Gaetano andS. Garattini). Raven Press, New York 1978."},{"key":"BF01965075_CR23","first-page":"467","volume-title":"Platelets, a Multidisciplinary Approach","author":"J.L. Ambrus","year":"1978","unstructured":"J.L. Ambrus, C.M. Ambrus andH. Gastpar, Studies on platelets aggregation and platelet interaction with tumor cells. InPlatelets, a Multidisciplinary Approach, pp. 467\u2013480 (EdsG. De Gaetano andS. Garattini). Raven Press, New York 1978."},{"key":"BF01965075_CR24","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0014-2999(77)90125-X","volume":"43","author":"B.B. Vargaftig","year":"1977","unstructured":"B.B. Vargaftig andJ. Lefort,Acute hypotension due to carrageenan, arachidonic acid and slow reacting substance C in the rabbit: role of platelets and nature of pharmacological antagonism, Eur. J. Pharmac.43, 125\u2013141 (1977).","journal-title":"Eur. J. Pharmac."},{"key":"BF01965075_CR25","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1152\/ajplegacy.1946.145.3.273","volume":"145","author":"A.J. Quick","year":"1945","unstructured":"A.J. Quick, R.K. Ota andI.D. Baronofsky,On the thrombopenia of anaphylactic and peptone shock, Am. J. Physiol.145, 273\u2013278 (1945).","journal-title":"Am. J. Physiol."},{"key":"BF01965075_CR26","volume-title":"Lectures on Biostatistics","author":"D. Colquhoun","year":"1971","unstructured":"D. Colquhoun,Lectures on Biostatistics. Clarendon Press, Oxford 1971."},{"key":"BF01965075_CR27","unstructured":"G. Ghielmetti andC. Trinchera, Process for the production of lysozyme, Br. Patent 1,110, 466 (1968)."},{"key":"BF01965075_CR28","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1055\/s-0038-1654248","volume":"24","author":"D.C. Macmillan","year":"1970","unstructured":"D.C. Macmillan andA.K. Sim,A comparative study of platelet aggregation in man and laboratory animals, Thromb. Diath. haemorrh.24, 385\u2013394 (1970).","journal-title":"Thromb. Diath. haemorrh."},{"key":"BF01965075_CR29","first-page":"45","volume-title":"Platelets, a Multidisciplinary Approach","author":"W.J. Dodds","year":"1978","unstructured":"W.J. Dodds, Platelet function in animals: species specificities. InPlatelets, a Multidisciplinary Approach, pp. 45\u201359 (EdsG. De Gaetano andS. Garattini). Raven Press, New York 1978."},{"key":"BF01965075_CR30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0049-3848(79)90047-1","volume":"15","author":"G. Kindness","year":"1979","unstructured":"G. Kindness, W.F. Long, F.B. Williamson andJ. Boyd,Effects of carrageenan on the aggregation of human blood platelets, Throm. Res.15, 3\u201315 (1979).","journal-title":"Throm. Res."},{"key":"BF01965075_CR31","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.2042-7158.1979.tb13457.x","volume":"31","author":"R.M. McMillan","year":"1979","unstructured":"R.M. McMillan, D.E. MacIntyre andJ.L. Gordon,Stimulation of human platelets by carrageenan, J. Pharm. Pharmac.31, 148\u2013152 (1979).","journal-title":"J. Pharm. Pharmac."},{"key":"BF01965075_CR32","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/j.2042-7158.1980.tb13058.x","volume":"32","author":"B.B. Vargaftig","year":"1980","unstructured":"B.B. Vargaftig, F. Fouque, M. Chignard andC. Dumarey,Carrageenan-induced activation of human platelets is independent of phospholipase A 2 and of formation of thromboxane, J. Pharm. Pharmac.32, 740\u2013745 (1980).","journal-title":"J. Pharm. Pharmac."},{"key":"BF01965075_CR33","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/newbio236045a0","volume":"236","author":"H. Shio","year":"1972","unstructured":"H. Shio andP. Ramwell,Effect of prostaglandin E 2 and aspirin on the secondary aggregation of human platelets, Nature New Biol.236, 45\u201346 (1972).","journal-title":"Nature New Biol."},{"key":"BF01965075_CR34","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.2042-7158.1977.tb11293.x","volume":"29","author":"B.B. Vargaftig","year":"1977","unstructured":"B.B. Vargaftig,Carrageenan and thrombin trigger prostaglandin synthetase-independent aggregation of rabbit platelets: inhibition by phospholipase A 2 inhibitors, J. Pharm. Pharmac.29, 222\u2013228 (1977).","journal-title":"J. Pharm. Pharmac."},{"key":"BF01965075_CR35","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1073\/pnas.76.4.1765","volume":"76","author":"F.A. Fitzpatrick","year":"1979","unstructured":"F.A. Fitzpatrick andD.A. Stringfellow,Prostaglandin D 2 formation by malignant melanoma cells correlates inversely with cellular metastatic potential, Proc. natn. Acad. Sci. USA76, 1765\u20131769 (1979).","journal-title":"Proc. natn. Acad. Sci. USA"},{"key":"BF01965075_CR36","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0090-6980(79)90037-6","volume":"17","author":"A. Bennett","year":"1979","unstructured":"A. Bennett, J. Houghton, D. J. Leaper andJ.K. Stamford,Cancer growth, response to treatment and survival time in mice: beneficial effect of the prostaglandin synthesis inhibitor flurbiprofen, Prostaglandins17, 179\u2013191 (1979).","journal-title":"Prostaglandins"},{"key":"BF01965075_CR37","first-page":"93","volume":"26","author":"R.M. Schultz","year":"1979","unstructured":"R.M. Schultz, J.N. Stoychkov, N. Pavlidis, M.A. Chirigos andZ.L. Olkowski,Role of E-type prostaglandins in the regulation of interferon treated macrophage cytotoxic activity, J. Reticuloendothel. Soc.26, 93\u2013102 (1979).","journal-title":"J. Reticuloendothel. Soc."},{"key":"BF01965075_CR38","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.4049\/jimmunol.124.6.2682","volume":"124","author":"M.J. Brunda","year":"1980","unstructured":"M.J. Brunda, R.B. Herberman andH.T. Holden,Inhibition of murine natural killer cell activity by prostaglandins, J. Immun.124, 2682\u20132687 (1980).","journal-title":"J. Immun."},{"key":"BF01965075_CR39","first-page":"61","volume":"10","author":"R.M. Schultz","year":"1981","unstructured":"R.M. Schultz,Factors limiting tumoricidal function of interferon-induced effector systems, activated macrophages and natural killer cells, Cancer Immunol. Immunother.10, 61\u201366 (1981).","journal-title":"Cancer Immunol. Immunother."},{"key":"BF01965075_CR40","unstructured":"C. Bianchi,Is Fleming's lysozyme an analgesic agent? Experiments on mice, Clin. exp. Pharmac. Physiol. (in press)."},{"key":"BF01965075_CR41","doi-asserted-by":"crossref","first-page":"182","DOI":"10.4049\/jimmunol.122.1.182","volume":"122","author":"J.Y. Djeu","year":"1979","unstructured":"J.Y. Djeu, J.A. Heinbaugh, H.T. Holden andR.B. Herberman,Role of macrophages in the augmentation of mouse natural killer cell activity by poly I\u2236C and interferon, J. Immun.122, 182\u2013188 (1979).","journal-title":"J. Immun."},{"key":"BF01965075_CR42","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1600-065X.1979.tb00266.x","volume":"44","author":"G. Cudkowicz","year":"1979","unstructured":"G. Cudkowicz andP.S. Hochman,Do natural killer cells engage in regulated reactions against self to ensure homeostasis? Immunol. Rev.44, 13\u201341 (1979), quoted by R.M. Schultz.","journal-title":"Immunol. Rev."}],"container-title":["Agents and Actions"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01965075.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01965075\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01965075","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,28]],"date-time":"2024-01-28T07:14:09Z","timestamp":1706426049000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01965075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1982,10]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1982,10]]}},"alternative-id":["BF01965075"],"URL":"https:\/\/doi.org\/10.1007\/bf01965075","relation":{},"ISSN":["0065-4299","1420-908X"],"issn-type":[{"value":"0065-4299","type":"print"},{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1982,10]]}}}